scholarly journals In Vitro Antifungal Activity of a Medicinal Plant Extract Mixture Against Candida Species Isolated from Patients with Oral Stomatitis

2019 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Gonca Erkose Genc ◽  
Ozcan Sahinkaya ◽  
Candan Demir ◽  
Ozgul Kisa ◽  
Dilek Satana
Keyword(s):  
Antifungal Activity ◽  
Medicinal Plant ◽  
Plant Extract ◽  
Candida Species ◽  
In Vitro Antifungal Activity

In vitro antifungal activity of the flavonoid baicalein against Candida species

2012 ◽  
Vol 61 (12) ◽  
pp. 1704-1708 ◽  
Author(s):  
Rosana Serpa ◽  
Emanuele J. G. França ◽  
Luciana Furlaneto-Maia ◽  
Célia G. T. J. Andrade ◽  
Andréa Diniz ◽  
...  
Keyword(s):  
Antifungal Activity ◽  
Candida Species ◽  
In Vitro Antifungal Activity

scholarly journals In vitro antifungal activity against Candida species of Sri Lankan orthodox black tea (Camellia sinensis L.) belonging to different agro-climatic elevations

2017 ◽  
Vol 5 (2) ◽  
pp. 66-69 ◽  
Author(s):  
Wanigasekara Daya Ratnasooriya ◽  
◽  
Sachitra Gayanthi Ratnasooriya ◽  
Chatura Dayendra Tissa Ratnasooriya ◽  
Ranga Dissanayake ◽  
...  
Keyword(s):  
Antifungal Activity ◽  
Camellia Sinensis ◽  
Candida Species ◽  
Black Tea ◽  
Sri Lankan ◽  
In Vitro Antifungal Activity

In vitro antifungal activity of phenothiazines and their combination with amphotericin B against different Candida species

Mycoses ◽  
2011 ◽  
Vol 54 (6) ◽  
pp. e737-e743 ◽  
Author(s):  
László Galgóczy ◽  
Andrea Bácsi ◽  
Mónika Homa ◽  
Máté Virágh ◽  
Tamás Papp ◽  
...  
Keyword(s):  
Antifungal Activity ◽  
Amphotericin B ◽  
Candida Species ◽  
In Vitro Antifungal Activity

In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species

2015 ◽  
Vol 31 (11) ◽  
pp. 1801-1809 ◽  
Author(s):  
Jhon J. Artunduaga Bonilla ◽  
Daissy J. Paredes Guerrero ◽  
Clara I. Sánchez Suárez ◽  
Claudia C. Ortiz López ◽  
Rodrigo G. Torres Sáez
Keyword(s):  
Silver Nanoparticles ◽  
Antifungal Activity ◽  
Candida Species ◽  
Fluconazole Resistant ◽  
In Vitro Antifungal Activity

scholarly journals In Vitro Antifungal Activity of Luliconazole, Efinaconazole, and Nine Comparators Against Aspergillus and Candida Strains Isolated from Otomycosis

2021 ◽  
Vol 14 (4) ◽  
Author(s):  
Gholamreza Shokoohi ◽  
Reza Rouhi ◽  
Mohammad Etehadnezhad ◽  
Bahram Ahmadi ◽  
Javad Javidnia ◽  
...  
Keyword(s):  
Antifungal Activity ◽  
Candida Species ◽  
Fungal Pathogens ◽  
Antifungal Agents ◽  
Geometric Mean ◽  
Antifungal Drugs ◽  
High Recurrence Rate ◽  
Broth Microdilution ◽  
In Vitro Antifungal Activity

Background: Aspergillus and Candida species are the most commonly identified fungal pathogens in otomycosis. However, we usually encounter some difficulties in its treatment because many patients show resistance to antifungal agents and present a high recurrence rate. Objectives: The current research was conducted to compare the in vitro activities of luliconazole (LUL), and efinaconazole (EFN) and the nine comparators on Aspergillus and Candida strains isolated from otomycosis. Methods: The in vitro activities of nine common antifungal drugs (amphotericin B (AMB), voriconazole (VRC), fluconazole (FLU), itraconazole (ITC), ketoconazole (KTO), clotrimazole (CLO), nystatin (NYS), terbinafine (TRB), and caspofungin (CAS)) and two novel new azoles (LUL and EFN) against of 108 clinical isolates of Aspergillus and Candida species obtained from otomycosis were assessed according to the CLSI broth microdilution document. Results: The LUL and EFN had the geometric mean minimum inhibitory concentrations (GM MICs) of 0.098 and 0.109 μg/mL against all Aspergillus strains, respectively. Furthermore, the GM MICs of all Candida isolates for LUL, EFN, CAS, CLO, VRC, AMB, ITC, KTO, FLU, NYS, and TRB were calculated to be 0.133, 0.144, 0.194, 0.219, 0.475, 0.537, 0.655, 1.277, 4.905, 9.372, and 13.592 μg/mL, respectively. Additionally, 6 (35.29%), 2 (11.7%), and 1 (5.88%) Candida isolates were resistant to FLU, CAS, and VRC, respectively. Conclusions: As the findings indicated, LUL and EFN showed the lowest GM MIC values against the examined species. Accordingly, these novel imidazole and triazole antifungal agents can be regarded as proper candidates for the treatment of otomycosis caused by Aspergillus and Candida strains.

scholarly journals In vitro antifungal activity of Myracrodruon urundeuva Allemão against human vaginal Candida species

2017 ◽  
Vol 89 (3 suppl) ◽  
pp. 2423-2432 ◽  
Author(s):  
FERNANDO A. DE OLIVEIRA ◽  
VANESSA C. RORATO ◽  
ADRIANA A. ALMEIDA-APOLONIO ◽  
ALLAN B. RODRIGUES ◽  
ALINE L. DE BARROS ◽  
...  
Keyword(s):  
Antifungal Activity ◽  
Candida Species ◽  
In Vitro Antifungal Activity

In Vitro Antifungal Activity of Various Persian Cultivars of Punica granatum L. Extracts Against Candida species

2015 ◽  
Vol 10 (3) ◽  
Author(s):  
Shahindokht Bassiri-Jahromi ◽  
Farzad Katiraee ◽  
Mannan Hajimahmoodi ◽  
Ehsan Mostafavi ◽  
Malihe Talebi. ◽  
...  
Keyword(s):  
Antifungal Activity ◽  
Candida Species ◽  
Punica Granatum ◽  
Punica Granatum L ◽  
In Vitro Antifungal Activity

scholarly journals In vitro Antifungal Activity of Ravuconazole Against Isolates of Dermatophytes and Candida Species from Patients with Dermatomycoses

2014 ◽  
Vol 55 (4) ◽  
pp. J157-J163 ◽  
Author(s):  
Hideyo Yamaguchi ◽  
Fumiaki Ikeda ◽  
Takako Iyoda ◽  
Makoto Suzuki ◽  
Takashi Mikawa
Keyword(s):  
Antifungal Activity ◽  
Candida Species ◽  
In Vitro Antifungal Activity
Sign in / Sign up

Export Citation Format

Share Document